Volume 11, Issue 4 pp. 439-446
Article
Full Access

Serum type III procollagen peptide: Indicator for pulmonary fibrosis: II. Application in 80 asbestos insulation workers

Isao Okazaki MD

Corresponding Author

Isao Okazaki MD

Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

Department of Preventive Medicine and Public Health, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, JapanSearch for more papers by this author
Dr. Katsuya Maruyama MD

Dr. Katsuya Maruyama MD

Department of Internal Medicine, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

Search for more papers by this author
Yumiko Kobayashi MD

Yumiko Kobayashi MD

Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

Search for more papers by this author
Ruth Lilis MD

Ruth Lilis MD

Division of Environmental and Occupational Medicine, Department of Community Medicine, Mount Sinai School of Medicine, The City University of New York, New York

Search for more papers by this author
Yasunosuke Suzuki MD

Yasunosuke Suzuki MD

Division of Environmental and Occupational Medicine, Department of Community Medicine, Mount Sinai School of Medicine, The City University of New York, New York

Search for more papers by this author
First published: 1987
Citations: 6

Abstract

An assay for type III procollagen peptide (P-III-P) was applied to serum from 80 asbestos insulation workers in order to evaluate its relationship with pulmonary and pleural fibrosis. The serum peptide levels of 16 control workers were 7.8 ± 2.0 ng/ml (mean ± SD). An association between the serum values of P-III-P and the profusion of small irregular opacities on chest X-rays was noted. The levels in the group with moderate interstitial pulmonary fibrosis [profusion category 2 (2/1, 2/2, and 2/3)] and with marked interstitial pulmonary fibrosis [profusion category 3(3/3)] were 9.9 ± 2.3 ng/ml (n = 5) and thus tended to be higher than those of 16 control workers (p<0.1). On the other hand, there was not correlation between serum peptide levels and pleural lesions nor between the former and duration of asbestos exposure. From the results of the investigation [part I of which is reported elsewhere (Okazaki et al, 1986)] this assay may be useful for detecting individuals with a more marked tendency for progression of interstitial pulmonary fibrosis due to asbestos exposure in insulation work.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.